"Das Universitätsklinikum Brandenburg an der Havel ist ein Krankenhaus der höchsten Versorgungsstufe und im Verbund der MHB Universitätskliniken. Es versorgt jedes Jahr rund 26.000 stationäre und 48.000 ambulante Patienten in 15 Fachabteilungen. Mit medizinischer Exzellenz, innovativen Therapien und interdisziplinären Teams arbeiten unsere über 2000 Mitarbeiterinnen und Mitarbeiter an einem gemeinsamen Ziel: der Sicherung erstklassiger Behandlungsqualität durch die Verknüpfung von Lehre, Forschung und Krankenversorgung. Für unsere Patienten. Für kommende Medizinergenerationen. Und als wichtiger Partner für niedergelassene Ärzte in der Region."

During the past decade, Städtisches Klinikum Brandenburg conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 4 clinical trials were completed, i.e. on average, 16% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Städtisches Klinikum Brandenburg" #1 sponsor was "Celgene" with 7 trials, followed by "Biotronik SE & Co. KG" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "AIO-Studien-gGmbH" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Städtisches Klinikum Brandenburg" #1 collaborator was "Novo Nordisk A/S" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Städtisches Klinikum Brandenburg" are "Crohn Disease" (5 trials), "Eosinophilic Esophagitis" (3 trials), "Ulcerative Colitis" (3 trials), "Heart Failure" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Städtisches Klinikum Brandenburg" in a lesser frequency.

Most popular intervention types in "Städtisches Klinikum Brandenburg" are "Drug" (23 trials), "Device" (6 trials), "Other" (6 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "CC-93538" (2 trials), "GED-0301" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Städtisches Klinikum Brandenburg" are 27 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Städtisches Klinikum Brandenburg". undefined are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Städtisches Klinikum Brandenburg, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Städtisches Klinikum Brandenburg, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Städtisches Klinikum Brandenburg has several departments that took part in Clinical trials: "Hamatologische Sprechstunde" - 2 trials